MedTrace Logo

Efficacy and Safety of Peri-operative Pregabalin After Radical Cystectomy

NCT02724293 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-03-31

No results posted yet for this study

Summary

This study compares analgesic efficacy, and safety of three different doses of peri-operative pregabaline to placebo following radical cystectomy.

Conditions

  • Postoperative Pain Following Radical Cystectomy

Interventions

DRUG

pregabaline 300 mg once.

patients received pregabaline 300 mg 2 hours pre-operatively.

DRUG

pregabaline 300 mg twice.

patients received pregabaline 300 mg 2 hours pre-operatively, and 12 hours later.

DRUG

pregabaline 600 mg once.

patients received pregabaline 600 mg 2 hours pre-operatively.

DRUG

placebo

patients received placebo

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-10-31
Completion
2015-11-30

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02724293 on ClinicalTrials.gov